retatrutide drug retatrutide Eli Lilly's experimental obesity drug

A recent study of a clinical trial of 483 adults found that nearly 18% did not respond to the drugs

The Benefits of Microdosing GLP-1 Medications While standard doses of GLP-1 medications are typically used for weight loss or diabetes management, microdosing offers a lower-dose alternative that can provide significant benefits for individuals not aiming to lose substantial weight

Weight loss on these medications can include lean mass loss alongside fat loss

Although these two drugs were originally developed to improve glycemic control in people with type 2 diabetes, they simultaneously cause significant weight loss in these patients, without too many major side effects, and could therefore represent a new therapeutic strategy for the normalization of body weight